“Exploiting Lysosomal Vulnerabilities: A Novel Therapeutic Strategy to Induce Immunogenic Cell Death in Oncogene-Addicted Cancers”, WAJHN, vol. 1, no. 4, pp. 1–4, Dec. 2025, doi: 10.63954/neaydp61.